Search Results
Policy Issues
In June 2013, the Supreme Court determined that DNA in its natural form cannot be patented.
The Genomics Landscape
NHGRI medical genetics training programs provide an array of education opportunities
… discuss SARS-CoV-2 viral variants Four potential COVID-19 therapeutics enter Phase 2/3 testing in NIH ACTIV-2 trial NIH …
File
… infor- mation will provide a completely new approach to therapeutics, with the dose of a drug being individually … does not invest in research aimed at diag- nostics or therapeutics for diseases that are predominant in developing …
News Release
NHGRI researchers will present four platform talks and 55 posters to highlight the institute's diverse portfolio at the 65th annual meeting of ASHG.
Staff
Dr. Oleg Shchelochkov is Director of NHGRI Clinical and Laboratory Residencies and Fellowships, and an Associate Investigator in the Office of the Clinical Director.
The Genomics Landscape
In the January 2019 edition of The Genomics Landscape, NHGRI Director Dr. Eric Green honors NIAMS Director, Stephen Katz, M.D., Ph.D.
… and validating promising biological targets for therapeutics. In particular, his leadership role in the …
The Genomics Landscape
In the June 2018 issue of The Genomics Landscape, NHGRI Director Eric Green highlights the success of The Cancer Genome Atlas.
The Genomics Landscape
In the May 2021 issue of the Genomics Landscape, NHGRI Director, Eric Green, M.D., Ph.D. notes that a number of individuals with strong ties to NHGRI have been nominated and/or appointed to serve on the White House Science Team.
… saliva can spread novel coronavirus Clinical trial of therapeutics for severely ill hospitalized COVID-19 patients …
File
… (CPIC)–Genes encoding proteins that are targets of cancer therapeutics–Genes recognized as clinically actionable …